Pronto Diagnostics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Pronto Diagnostics General Information

Description

Distributor of molecular diagnostic products and services intended to serve the healthcare industry. The company develops, produces, and distributes its own SNP-detection kits, which provide rapid and accurate assays for detecting polymorphisms in DNA sequences associated with genetic diseases and predisposition to disease, along with services like genetic testing, genetic counseling, and sequencing tests.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kiryat Atidim
  • Tel Aviv
  • Israel
+972
Primary Industry
Distributors/Wholesale
Other Industries
Distributors (Healthcare)
Diagnostic Equipment
Parent Company
Corporate Office
  • Kiryat Atidim
  • Tel Aviv
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pronto Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pronto Diagnostics‘s full profile, request access.

Request a free trial

Pronto Diagnostics Patents

Pronto Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2139433-A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor Inactive 02-Jul-1992
EP-0648222-A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor Active 02-Jul-1992
EP-0648222-B1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor Inactive 02-Jul-1992
EP-0648222-A4 Methods of single nucleotide primer extension to detect specific alleles and kits therefor. Active 02-Jul-1992
ES-2191666-T3 Simple nucleotide cebing extension methods to detect specific alelos and appropriate kit for it. Inactive 02-Jul-1992 C12Q1/6883
To view Pronto Diagnostics’s complete patent history, request access »

Pronto Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pronto Diagnostics FAQs

  • When was Pronto Diagnostics founded?

    Pronto Diagnostics was founded in 2003.

  • Where is Pronto Diagnostics headquartered?

    Pronto Diagnostics is headquartered in Tel Aviv, Israel.

  • What is the size of Pronto Diagnostics?

    Pronto Diagnostics has 19 total employees.

  • What industry is Pronto Diagnostics in?

    Pronto Diagnostics’s primary industry is Distributors/Wholesale.

  • Is Pronto Diagnostics a private or public company?

    Pronto Diagnostics is a Private company.

  • What is the current valuation of Pronto Diagnostics?

    The current valuation of Pronto Diagnostics is .

  • What is Pronto Diagnostics’s current revenue?

    The current revenue for Pronto Diagnostics is .

  • When was Pronto Diagnostics acquired?

    Pronto Diagnostics was acquired on 19-Feb-2023.

  • Who acquired Pronto Diagnostics?

    Pronto Diagnostics was acquired by Novolog.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process